Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation ConditioningMelphalanCombined Modality TherapyBone Marrow TransplantationTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRemission InductionSalvage TherapyStem CellsHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinDisease-Free SurvivalHodgkin DiseaseRecurrenceEtoposideLiver TransplantationCarmustineMyeloablative AgonistsCyclophosphamideGraft vs Host DiseaseCytarabineBone Marrow PurgingSurvival RateGraft SurvivalHematologic NeoplasmsVincristineWhole-Body IrradiationHematopoietic Stem CellsSurvival AnalysisRetrospective StudiesThiotepaBusulfanAntigens, CD34Kidney TransplantationLymphoma, Mantle-CellDexamethasoneAmyloidosisLeukapheresisCell TransplantationFollow-Up StudiesGranulocyte Colony-Stimulating FactorPrognosisThalidomideAntibodies, Monoclonal, Murine-DerivedBoronic AcidsPyrazinesAntineoplastic Agents, AlkylatingDoxorubicinTime FactorsLymphoma, FollicularPrednisoneMesenchymal Stem Cell TransplantationAutograftsTransplantation ChimeraTissue DonorsLymphoma, T-Cell, PeripheralLymphomaNeoplasm, ResidualHeart TransplantationCord Blood Stem Cell TransplantationIfosfamideLung TransplantationLeukemia, Myeloid, AcuteImmunosuppressive AgentsPodophyllotoxinMyelodysplastic SyndromesIdarubicinAntineoplastic AgentsInduction ChemotherapyBlood Component RemovalLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyHistocompatibility TestingFeasibility StudiesOrgan TransplantationTransplantation ImmunologyEmbryonic Stem CellsGraft RejectionProspective StudiesBlood Transfusion, AutologousBone MarrowEnteropathy-Associated T-Cell LymphomaHematopoiesisLymphoma, B-CellCell DifferentiationAntibodies, MonoclonalLeukemia, Plasma CellInfusions, SpinalGraft vs Tumor EffectLeukemiaAdult Stem CellsNeoplasms, Second PrimaryMitoxantroneHistocompatibility